S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eileen P. Smith, MD
City of Hope Medical Center
Study Chair - Louis S. Constine, MD
James P. Wilmot Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Davis Cancer Center
Sacramento, California, United States
- Mountain States Tumor Institute at St. Luke'S Regional Medical Center
Boise, Idaho, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Winfield
Winfield, Kansas, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Legacy Mount Hood Medical Center
Gresham, Oregon, United States
- Providence Milwaukie Hospital
Milwaukie, Oregon, United States
- Adventist Medical Center
Portland, Oregon, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Legacy Emanuel Hospital and Health Center and Children'S Hospital
Portland, Oregon, United States
- Legacy Good Samaritan Hospital & Comprehensive Cancer Center
Portland, Oregon, United States
- Providence Cancer Center at Providence Portland Medical Center
Portland, Oregon, United States
- Providence St. Vincent Medical Center
Portland, Oregon, United States
- Legacy Meridian Park Hospital
Tualatin, Oregon, United States
- Thompson Cancer Survival Center
Knoxville, Tennessee, United States
- Auburn Regional Center for Cancer Care
Auburn, Washington, United States
- St. Joseph Cancer Center
Bellingham, Washington, United States
- Olympic Hematology and Oncology
Bremerton, Washington, United States
- Providence Centralia Hospital
Centralia, Washington, United States
- St. Francis Hospital
Federal Way, Washington, United States
- Columbia Basin Hematology
Kennewick, Washington, United States
- Providence St. Peter Hospital Regional Cancer Center
Olympia, Washington, United States
- Good Samaritan Cancer Center
Puyallup, Washington, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2005
- Primary completion
- 30 Nov 2014
- Completion
- 31 Dec 2017
- Last update posted
- 1 Mar 2018
- Registered enrollment
- 98
- Registry id
- NCT00233987
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.